Rectal sarcomatoid carcinoma

Summary

Rectal sarcomatoid carcinoma (MONDO:0004196) is a cancer. A subtype of sarcomatoid carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	rectal sarcomatoid carcinoma
Mondo ID	MONDO:0004196
DOID	DOID:7356
NCIT	C5556
UMLS	C1335689
MedGen	235533
Anatomy (UBERON)	UBERON:0001052
Is cancer (heuristic)	yes

Also known as: rectal sarcomatoid cancer · rectal sarcomatoid carcinoma · rectal spindle cell carcinoma · rectum sarcomatoid carcinoma · sarcomatoid carcinoma of rectum · sarcomatoid carcinoma of the rectum

Disease family

This is a subtype of sarcomatoid carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › sarcomatoid carcinoma › rectal sarcomatoid carcinoma

Related subtypes (7): sarcomatoid transitional cell carcinoma, sarcomatoid basal cell carcinoma, sarcomatoid renal cell carcinoma, pleomorphic carcinoma, lung sarcomatoid carcinoma, thymic sarcomatoid carcinoma, sarcomatoid squamous cell carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.